OverviewSuggest Edit

A worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 60 independent distributors into over 100 countries.
TypePublic
Founded1989
HQMountain View, US
Websiteiridex.com
Employee Ratings3.2

Latest Updates

Employees (est.) (Dec 2018)114(-1%)
Job Openings2
Revenue (FY, 2018)$42.6 M(+3%)
Share Price (Nov 2019)$2

IRIDEX Office Locations

IRIDEX has an office in Mountain View
Mountain View, US (HQ)
1212 Terra Bella Ave
Show all (1)

IRIDEX Financials and Metrics

IRIDEX Revenue

Embed Graph
View revenue for all periods
IRIDEX's revenue was reported to be $42.60 m in FY, 2018
USD

Revenue (Q3, 2019)

10.7m

Gross profit (Q3, 2019)

4.3m

Gross profit margin (Q3, 2019), %

40.2%

Net income (Q3, 2019)

(1.8m)

EBIT (Q3, 2019)

(1.9m)

Market capitalization (12-Nov-2019)

27.8m

Closing stock price (12-Nov-2019)

2.0

Cash (28-Sep-2019)

12.9m
IRIDEX's current market capitalization is $27.8 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

38.3m42.8m41.8m46.2m41.6m42.6m

Revenue growth, %

12%(2%)11%

Cost of goods sold

19.7m21.4m21.8m25.3m26.1m25.1m

Gross profit

18.6m21.4m20.0m20.8m15.5m17.5m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

9.5m10.3m10.6m10.1m9.8m10.8m9.0m11.9m11.9m9.8m10.5m10.0m10.9m9.5m10.3m11.3m10.6m10.4m10.7m

Cost of goods sold

4.8m5.3m5.3m5.0m5.0m5.4m4.8m6.6m6.2m5.5m6.0m5.5m6.5m5.6m6.0m6.7m6.3m5.9m6.4m

Gross profit

4.7m5.1m5.3m5.1m4.8m5.4m4.2m5.3m5.7m4.2m4.5m4.5m4.4m3.9m4.3m4.6m4.3m4.5m4.3m

Gross profit Margin, %

50%49%50%51%49%50%47%44%48%43%43%45%40%41%41%40%40%44%40%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

13.4m13.3m10.0m23.7m21.7m21.2m

Inventories

10.6m9.1m11.1m11.6m9.4m8.8m

Current Assets

32.0m32.9m30.8m45.9m39.5m39.6m

PP&E

543.0k735.0k1.1m1.5m1.4m1.2m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

14.1m14.0m12.9m13.0m10.2m13.1m12.2m10.5m11.5m9.6m23.9m24.6m22.8m18.5m16.0m23.7m17.2m15.6m12.9m

Inventories

10.0m9.9m9.8m9.6m11.2m9.9m10.2m11.1m12.1m12.7m11.7m11.4m10.7m9.3m9.1m8.7m8.7m9.0m8.9m

Current Assets

30.4m31.3m30.5m30.8m31.4m33.2m31.9m31.4m32.7m31.4m45.0m43.5m41.5m34.9m32.9m41.4m35.1m33.3m31.2m

PP&E

526.0k575.0k720.0k748.0k1.1m1.0m1.1m1.1m1.2m1.4m1.7m1.6m1.4m1.5m1.4m1.3m1.1m991.0k876.0k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

2.2m10.0m474.0k(11.7m)(12.9m)(12.8m)

Depreciation and Amortization

490.0k420.0k522.0k648.0k858.0k809.0k

Inventories

(2.5m)1.5m(2.0m)(537.0k)2.1m463.0k

Accounts Payable

173.0k(520.0k)465.0k(229.0k)(270.0k)788.0k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

1.8m487.0k784.0k490.0k442.0k246.0k(652.0k)101.0k(227.0k)(898.0k)(1.9m)(4.6m)(7.7m)(3.6m)(6.9m)(10.0m)(3.0m)(5.5m)(7.3m)

Depreciation and Amortization

364.0k108.0k203.0k142.0k291.0k461.0k207.0k417.0k660.0k193.0k395.0k617.0k211.0k354.0k518.0k

Inventories

(2.0m)747.0k852.0k9.6m11.2m9.9m10.2m(36.0k)(1.0m)(1.6m)(85.0k)255.0k974.0k75.0k282.0k533.0k66.0k(207.0k)(188.0k)

Accounts Payable

(28.0k)(508.0k)(270.0k)1.8m2.6m2.5m2.1m473.0k971.0k249.0k(50.0k)(214.0k)(130.0k)252.0k519.0k828.0k(116.0k)(320.0k)(86.0k)
USDY, 2019

Financial Leverage

1.5 x
Show all financial metrics

IRIDEX Online and Social Media Presence

Embed Graph

IRIDEX News and Updates

Ken Ludlum Appointed to IRIDEX Board of Directors

MOUNTAIN VIEW, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that Ken Ludlum has been appointed to its Board of Directors, effective …

IRIDEX Announces 2018 Fourth Quarter and Full Year Financial Results

MOUNTAIN VIEW, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and year ended December 29, 2018.

Ophthalmic Lasers Global Market 2018: Key Players – Abbott Laboratories, Carl Zeiss, Ellex Medical Lasers, IRIDEX Corporation, Lumenis Ltd.

Ophthalmic Lasers -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024 Posted via Industry Today. Follow us on Twitter @IndustryToday

IRIDEX Announces Preliminary Operational and Financial Results for 2018 Fourth Quarter and Full Year

MOUNTAIN VIEW, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary operational and financial results for the fourth quarter and full year ended December 29, 2018.

Leading Ophthalmologists to Discuss the Value of IRIDEX Solutions at AAO

Glaucoma and Retina Specialists Will Discuss the Benefits of MicroPulse® Technology

Medical Laser Systems Market 2018 Global Analysis By Key Players – Alcon, Cynosure, IRIDEX, Lumenis, Syneron Medical

WiseGuyReports.Com Publish a New Market Research Report On –“ Medical Laser Systems Market 2018 Global Analysis By Key Players – Alcon, Cynosure, IRIDEX, Lumenis, Syneron Medical”. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

IRIDEX Blogs

IRIDEX to Report Third Quarter 2019 Financial Results on November 7, 2019

IRIDEX to Report Third Quarter 2019 Financial Results on November 7, 2019 Content Import Thu, 10/24/2019 - 16:03 IRIDEX to Report Third Quarter 2019 Financial Results on November 7, 2019 10/24/19 This release is a backfill from a News Wire Gene…

41 Robert Gunst

41 Robert Gunst marco.guevara@… Wed, 08/14/2019 - 13:20 Member of the Audit Committee Member of the Nominating and Governance Committee Robert Gunst Director Mr. Gunst has served as a director of the Company since July 2019. Mr. Gunst served on the Board of Dire…

99999 Scott Shuda

99999 Scott Shuda marco.guevara@… Wed, 08/14/2019 - 13:15 Member of the Audit Committee Member of the Compensation Committee Scott Shuda Director Mr. Shuda has served as a director of the Company since April 2019. Mr. Shuda has been a member of the board of dir…

IRIDEX Announces 2019 Second Quarter Financial Results

IRIDEX Announces 2019 Second Quarter Financial Results Content Import Tue, 08/06/2019 - 16:03 IRIDEX Announces 2019 Second Quarter Financial Results 08/06/19 This release is a backfill from a News Wire Earnings MOUNTAIN VIEW, Calif.,…

Q2 2019 IRIDEX Earnings Conference Call

Q2 2019 IRIDEX Earnings Conference Call marco.guevara@… Tue, 07/23/2019 - 16:12 Q2 2019 IRIDEX Earnings Conference Call Display "add to calendar" true Event Type Earnings Conference Call Click here for webcast …

IRIDEX to Report Second Quarter 2019 Financial Results on August 6, 2019

MOUNTAIN VIEW, Calif. , July 23, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter of 2019 after the close of trading on Tuesday, August 6 , 2019.  The Company’s management team will host a corresponding

IRIDEX Frequently Asked Questions

  • When was IRIDEX founded?

    IRIDEX was founded in 1989.

  • How many employees does IRIDEX have?

    IRIDEX has 114 employees.

  • What is IRIDEX revenue?

    Latest IRIDEX annual revenue is $42.6 m.

  • What is IRIDEX revenue per employee?

    Latest IRIDEX revenue per employee is $373.7 k.

  • Who are IRIDEX competitors?

    Competitors of IRIDEX include Lumibird, LPKF Laser & Electronics and Avanos.

  • Where is IRIDEX headquarters?

    IRIDEX headquarters is located at 1212 Terra Bella Ave, Mountain View.

  • Where are IRIDEX offices?

    IRIDEX has an office in Mountain View.

  • How many offices does IRIDEX have?

    IRIDEX has 1 office.